Dr. Andrew Hendifar, MD
Claim this profileCedars-Sinai Medical Center
Expert in Pancreatic Cancer
Studies Cancer
22 reported clinical trials
43 drugs studied
About Andrew Hendifar, MD
Education:
- Earned an MD from Tulane University School of Medicine in 2003.
- Completed Internship and Residency at Los Angeles County + USC Medical Center (2006-2007).
- Undertook a Fellowship at the University of Southern California in 2010.
Experience:
- Over 20 years of experience in hematology and oncology.
- Affiliated with Cedars-Sinai Medical Center.
- Holds positions as Co-Director of the Hematology/Oncology Fellowship Program and Medical Director of Pancreatic Cancer at Cedars-Sinai Medical Center.
- Serves as an Associate Professor of Medicine at Cedars-Sinai Medical Center.
Area of expertise
1Pancreatic Cancer
Global LeaderStage IV
Stage III
BRAF
2Cancer
Stage IV
Stage III
EGFR negative
Affiliated Hospitals
Clinical Trials Andrew Hendifar, MD is currently running
Oral Ketamine
for Anxiety in Pancreatic Cancer Patients
This is a prospective, single center, double blind, randomized, crossover feasibility study of oral ketamine versus placebo for the treatment of anxiety in patients with pancreatic cancer currently receiving or within 12 weeks of receiving cancer targeted therapy. The primary objective is to determine the feasibility of enrolling subjects and treatment adherence. The secondary objectives are to describe the safety and tolerability. Exploratory objectives are to assess the effect of ketamine/placebo on Depression, Anxiety, Physical Function, Pain Interference, Pain Intensity, Fatigue, Sleep Disturbance, and Ability to Participate in Social Roles and Activities as measured by PROMIS Anxiety Short Form 7a and the PROMIS-29 Profile v2.1 of Patient Reported Outcomes, as well as changes in circulatory inflammatory cytokines, blood glutamine levels, and other biomarkers of anxiety and/or depression.
Recruiting0 awards Phase < 111 criteria
Lutetium Lu 177 Dotatate
for Lung Carcinoid Tumor
This trial studies the effect of lutetium Lu 177 dotatate in patients with advanced bronchial neuroendocrine tumors. Lutetium Lu 177 dotatate targets cancer cells with radiation, aiming to kill or shrink them while sparing healthy cells. The goal is to see if it works better than the usual treatment. Everolimus has been shown to help patients with various types of neuroendocrine tumors.
Recruiting1 award Phase 210 criteria
More about Andrew Hendifar, MD
Clinical Trial Related5 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Andrew Hendifar, MD has experience with
- Gemcitabine
- Pembrolizumab
- Lutetium Lu 177 Dotatate
- Ketorolac Tromethamine
- Pancrelipase
- Azeliragon
Breakdown of trials Andrew Hendifar, MD has run
Pancreatic Cancer
Cancer
Colorectal Cancer
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Hendifar, MD specialize in?
Andrew Hendifar, MD focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrew Hendifar, MD currently recruiting for clinical trials?
Yes, Andrew Hendifar, MD is currently recruiting for 4 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Andrew Hendifar, MD has studied deeply?
Yes, Andrew Hendifar, MD has studied treatments such as Gemcitabine, Pembrolizumab, Lutetium Lu 177 Dotatate.
What is the best way to schedule an appointment with Andrew Hendifar, MD?
Apply for one of the trials that Andrew Hendifar, MD is conducting.
What is the office address of Andrew Hendifar, MD?
The office of Andrew Hendifar, MD is located at: Cedars-Sinai Medical Center, Los Angeles, California 90048-1804 United States. This is the address for their practice at the Cedars-Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.